{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T01:25:07Z","timestamp":1787102707915,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Deutsches Krebsforschungszentrum (DKFZ)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Established screening programs for colorectal cancer (CRC) based on fecal immunochemical tests (FITs) employ fixed screening intervals of either one year or two years for all participants. We aimed to assess the potential design of risk-adapted FIT screening intervals based on quantitative values of the fecal hemoglobin concentration among FIT negative participants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using COSIMO, a previously validated simulation tool, we compared CRC risks in subgroups with initially negative FIT. Subgroups were stratified by stool hemoglobin levels at screening (&lt;\u20098 (low), 8-&lt;10 (medium), 10-&lt;17\u00a0\u00b5g (high) Hb\/g stool), a routinely available measure in FIT-based screening programs. Colorectal neoplasia prevalences at model start were informed by 6,661 screening colonoscopy participants in Germany at average CRC risk with negative FIT and available colonoscopy results (BLITZ study). Simulations were run for hypothetical cohorts of 100,000 individuals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 6,661 FIT-negative participants, 6,016 (90%), 273 (4%), and 372 (6%) were in the low, medium, and high-negative subgroups, respectively. In those low-negative, expected cancer detection rates were 0.17%, 0.30%, 0.42%, 0.53%, and 0.62%, after screening intervals of 1, 2, 3, 4, and 5 years, respectively. Cancer detection rates among the small groups of medium- and high-negative patients were up to six times higher and exceeded the expected 2-year detection rates of the low-negative group already after 1 year of follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Fecal hemoglobin concentrations among FIT negative participants may be a readily available, highly informative tool for defining risk-adapted annual or biennial FIT screening intervals.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12916-026-05138-7","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:06:02Z","timestamp":1787022362000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk-adapted intervals for colorectal cancer screening using fecal immunochemical tests: a modelling study based on the BLITZ cohort"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1348-3350","authenticated-orcid":false,"given":"Thomas","family":"Heisser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Seum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hoffmeister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"5138_CR1","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","volume":"394","author":"E Dekker","year":"2019","unstructured":"Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB. Colorectal cancer. Lancet. 2019;394:1467\u201380. https:\/\/doi.org\/10.1016\/S0140-6736(19)32319-0.","journal-title":"Lancet"},{"key":"5138_CR2","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1136\/gutjnl-2018-317293","volume":"68","author":"C Senore","year":"2019","unstructured":"Senore C, Basu P, Anttila A, Ponti A, Tomatis M, Vale DB, et al. Performance of colorectal cancer screening in the European Union Member States: data from the second European screening report. Gut. 2019;68:1232\u201344. https:\/\/doi.org\/10.1136\/gutjnl-2018-317293.","journal-title":"Gut"},{"key":"5138_CR3","doi-asserted-by":"publisher","first-page":"E1409","DOI":"10.3390\/cancers12061409","volume":"12","author":"R Cardoso","year":"2020","unstructured":"Cardoso R, Guo F, Heisser T, Hoffmeister M, Brenner H. Utilisation of Colorectal Cancer Screening Tests in European Countries by Type of Screening Offer: Results from the European Health Interview Survey. Cancers (Basel). 2020;12:E1409. https:\/\/doi.org\/10.3390\/cancers12061409.","journal-title":"Cancers (Basel)"},{"key":"5138_CR4","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1053\/j.gastro.2019.06.043","volume":"158","author":"U Ladabaum","year":"2020","unstructured":"Ladabaum U, Dominitz JA, Kahi C, Schoen RE. Strategies for Colorectal Cancer Screening. Gastroenterology. 2020;158:418\u201332. https:\/\/doi.org\/10.1053\/j.gastro.2019.06.043.","journal-title":"Gastroenterology"},{"key":"5138_CR5","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1001\/jama.2021.6238","volume":"325","author":"US Preventive Services Task Force","year":"2021","unstructured":"US Preventive Services Task Force. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. J Am Med Assoc. 2021;325:1965\u201377. https:\/\/doi.org\/10.1001\/jama.2021.6238.","journal-title":"J Am Med Assoc"},{"issue":"Suppl 1","key":"5138_CR6","doi-asserted-by":"publisher","first-page":"S139","DOI":"10.1016\/j.canep.2015.10.021","volume":"39","author":"P Armaroli","year":"2015","unstructured":"Armaroli P, Villain P, Suonio E, Almonte M, Anttila A, Atkin WS, et al. European Code against Cancer, 4th Edition: Cancer screening. Cancer Epidemiol. 2015;39(Suppl 1):S139\u2013152. https:\/\/doi.org\/10.1016\/j.canep.2015.10.021.","journal-title":"Cancer Epidemiol"},{"key":"5138_CR7","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.7326\/M23-1358","volume":"176","author":"T Niedermaier","year":"2023","unstructured":"Niedermaier T, Heisser T, Cardoso R, Hoffmeister M, Brenner H. Colonoscopy-Ascertained Prevalence of Advanced Neoplasia According to Fecal Hemoglobin Concentration in a Large Cohort of Fecal Immunochemical Test-Negative Screening Participants. Ann Intern Med. 2023;176:1569\u201371. https:\/\/doi.org\/10.7326\/M23-1358.","journal-title":"Ann Intern Med"},{"key":"5138_CR8","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1002\/ijc.33437","volume":"148","author":"T Heisser","year":"2021","unstructured":"Heisser T, Hoffmeister M, Brenner H. Effects of screening for colorectal cancer: Development, documentation and validation of a multistate Markov model. Int J Cancer. 2021;148:1973\u201381. https:\/\/doi.org\/10.1002\/ijc.33437.","journal-title":"Int J Cancer"},{"key":"5138_CR9","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1093\/aje\/kwr188","volume":"174","author":"H Brenner","year":"2011","unstructured":"Brenner H, Altenhofen L, Katalinic A, Lansdorp-Vogelaar I, Hoffmeister M. Sojourn Time of Preclinical Colorectal Cancer by Sex and Age: Estimates From the German National Screening Colonoscopy Database. Am J Epidemiol. 2011;174:1140\u20136. https:\/\/doi.org\/10.1093\/aje\/kwr188.","journal-title":"Am J Epidemiol"},{"key":"5138_CR10","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1158\/1055-9965.Epi-13-0162","volume":"22","author":"H Brenner","year":"2013","unstructured":"Brenner H, Altenhofen L, Stock C, Hoffmeister M. Natural history of colorectal adenomas: birth cohort analysis among 3.6 million participants of screening colonoscopy. Cancer Epidemiol Biomarkers Prev. 2013;22:1043\u201351. https:\/\/doi.org\/10.1158\/1055-9965.Epi-13-0162.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"5138_CR11","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1158\/1055-9965.Epi-14-0367","volume":"23","author":"H Brenner","year":"2014","unstructured":"Brenner H, Altenhofen L, Stock C, Hoffmeister M. Incidence of colorectal adenomas: birth cohort analysis among 4.3 million participants of screening colonoscopy. Cancer Epidemiol Biomarkers Prev. 2014;23:1920\u20137. https:\/\/doi.org\/10.1158\/1055-9965.Epi-14-0367.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"5138_CR12","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1002\/ijc.31716","volume":"143","author":"C Chen","year":"2018","unstructured":"Chen C, Stock C, Hoffmeister M, Brenner H. How long does it take until the effects of endoscopic screening on colorectal cancer mortality are fully disclosed? a Markov model study. Int J Cancer. 2018;143:2718\u201324. https:\/\/doi.org\/10.1002\/ijc.31716.","journal-title":"Int J Cancer"},{"key":"5138_CR13","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.gie.2018.12.021","volume":"89","author":"C Chen","year":"2019","unstructured":"Chen C, Stock C, Hoffmeister M, Brenner H. Optimal age for screening colonoscopy: a modeling study. Gastrointest Endosc. 2019;89:1017\u201325. https:\/\/doi.org\/10.1016\/j.gie.2018.12.021. .e12.","journal-title":"Gastrointest Endosc"},{"key":"5138_CR14","unstructured":"Statistisches Bundesamt (Federal Office of Statistics). Allgemeine Sterbetafel 2010\/2012. (General Life Table 2010\/2012). 2015. https:\/\/www-genesis.destatis.de. Accessed 7 Nov 2022."},{"key":"5138_CR15","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1016\/j.cgh.2016.10.018","volume":"15","author":"H Chen","year":"2017","unstructured":"Chen H, Werner S, Brenner H. Fresh vs Frozen Samples and Ambient Temperature Have Little Effect on Detection of Colorectal Cancer or Adenomas by a Fecal Immunochemical Test in a Colorectal Cancer Screening Cohort in Germany. Clin Gastroenterol Hepatol. 2017;15:1547\u2013e15565. https:\/\/doi.org\/10.1016\/j.cgh.2016.10.018.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5138_CR16","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1002\/ijc.30284","volume":"139","author":"K Weigl","year":"2016","unstructured":"Weigl K, Jansen L, Chang-Claude J, Knebel P, Hoffmeister M, Brenner H. Family history and the risk of colorectal cancer: The importance of patients\u2019 history of colonoscopy. Int J Cancer. 2016;139:2213\u201320. https:\/\/doi.org\/10.1002\/ijc.30284.","journal-title":"Int J Cancer"},{"key":"5138_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0002-9343(98)00338-6","volume":"106","author":"SJ Winawer","year":"1999","unstructured":"Winawer SJ. Natural history of colorectal cancer. Am J Med. 1999;106:3\u20136. https:\/\/doi.org\/10.1016\/S0002-9343(98)00338-6.","journal-title":"Am J Med"},{"key":"5138_CR18","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1053\/j.gastro.2012.06.001","volume":"143","author":"DA Lieberman","year":"2012","unstructured":"Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA, Levin TR. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2012;143:844\u201357. https:\/\/doi.org\/10.1053\/j.gastro.2012.06.001.","journal-title":"Gastroenterology"},{"key":"5138_CR19","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1055\/s-0033-1344548","volume":"45","author":"C Hassan","year":"2013","unstructured":"Hassan C, Quintero E, Dumonceau JM, Regula J, Brandao C, Chaussade S, et al. Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2013;45:842\u201351. https:\/\/doi.org\/10.1055\/s-0033-1344548.","journal-title":"Endoscopy"},{"key":"5138_CR20","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1136\/gutjnl-2011-300295","volume":"61","author":"V Cottet","year":"2012","unstructured":"Cottet V, Jooste V, Fournel I, Bouvier AM, Faivre J, Bonithon-Kopp C. Long-term risk of colorectal cancer after adenoma removal: a population-based cohort study. Gut. 2012;61:1180\u20136. https:\/\/doi.org\/10.1136\/gutjnl-2011-300295.","journal-title":"Gut"},{"key":"5138_CR21","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.cgh.2014.08.036","volume":"13","author":"H Brenner","year":"2015","unstructured":"Brenner H, Altenhofen L, Stock C, Hoffmeister M. Prevention, early detection, and overdiagnosis of colorectal cancer within 10 years of screening colonoscopy in Germany. Clin Gastroenterol Hepatol. 2015;13:717\u201323. https:\/\/doi.org\/10.1016\/j.cgh.2014.08.036.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5138_CR22","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.ejca.2015.03.020","volume":"51","author":"H Brenner","year":"2015","unstructured":"Brenner H, Altenhofen L, Stock C, Hoffmeister M. Expected long-term impact of the German screening colonoscopy programme on colorectal cancer prevention: Analyses based on 4,407,971 screening colonoscopies. Eur J Cancer. 2015;51:1346\u201353. https:\/\/doi.org\/10.1016\/j.ejca.2015.03.020.","journal-title":"Eur J Cancer"},{"key":"5138_CR23","doi-asserted-by":"publisher","first-page":"48168","DOI":"10.18632\/oncotarget.10178","volume":"7","author":"H Brenner","year":"2016","unstructured":"Brenner H, Kretschmann J, Stock C, Hoffmeister M. Expected long-term impact of screening endoscopy on colorectal cancer incidence: A modelling study. Oncotarget. 2016;7:48168\u201379. https:\/\/doi.org\/10.18632\/oncotarget.10178.","journal-title":"Oncotarget"},{"key":"5138_CR24","unstructured":"German Cancer Research Center (DKFZ), Department Clinical Epidemiology and Aging Reserach. Download Page for COSIMO Source Code. 2023. https:\/\/www.dkfz.de\/en\/klinepi\/download\/index.html. Accessed 20 June 2023."},{"key":"5138_CR25","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/j.1572-0241.2006.00390.x","volume":"101","author":"JC van Rijn","year":"2006","unstructured":"van Rijn JC, Reitsma JB, Stoker J, Bossuyt PM, van Deventer SJ, Dekker E. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol. 2006;101:343\u201350. https:\/\/doi.org\/10.1111\/j.1572-0241.2006.00390.x.","journal-title":"Am J Gastroenterol"},{"key":"5138_CR26","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1053\/j.gastro.2019.01.260","volume":"156","author":"S Zhao","year":"2019","unstructured":"Zhao S, Wang S, Pan P, Xia T, Chang X, Yang X, et al. Magnitude, Risk Factors, and Factors Associated With Adenoma Miss Rate of Tandem Colonoscopy: A Systematic Review and Meta-analysis. Gastroenterology. 2019;156:1661\u2013e167411. https:\/\/doi.org\/10.1053\/j.gastro.2019.01.260.","journal-title":"Gastroenterology"},{"key":"5138_CR27","unstructured":"Zentrum f\u00fcr Krebsregisterdaten. Krebsstatistiken f\u00fcr Deutschland - Interaktive Datenbank (Centre for Cancer Registry Data: Cancer Statistics for Germany - Interactive Database). 2021. https:\/\/www.krebsdaten.de\/Krebs\/DE\/Datenbankabfrage\/datenbankabfrage_stufe1_node.html. Accessed 7 Nov 2022."},{"key":"5138_CR28","doi-asserted-by":"publisher","first-page":"162","DOI":"10.7326\/0003-4819-150-3-200902030-00005","volume":"150","author":"S Hundt","year":"2009","unstructured":"Hundt S, Haug U, Brenner H. Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection. Ann Intern Med. 2009;150:162\u20139. https:\/\/doi.org\/10.7326\/0003-4819-150-3-200902030-00005.","journal-title":"Ann Intern Med"},{"key":"5138_CR29","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1016\/j.ejca.2013.04.023","volume":"49","author":"H Brenner","year":"2013","unstructured":"Brenner H, Tao S. Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy. Eur J Cancer. 2013;49:3049\u201354. https:\/\/doi.org\/10.1016\/j.ejca.2013.04.023.","journal-title":"Eur J Cancer"},{"key":"5138_CR30","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1053\/j.gastro.2017.09.018","volume":"154","author":"A Gies","year":"2018","unstructured":"Gies A, Cuk K, Schrotz-King P, Brenner H. Direct Comparison of Diagnostic Performance of 9 Quantitative Fecal Immunochemical Tests for Colorectal Cancer Screening. Gastroenterology. 2018;154:93\u2013104. https:\/\/doi.org\/10.1053\/j.gastro.2017.09.018.","journal-title":"Gastroenterology"},{"key":"5138_CR31","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1136\/gutjnl-2018-318198","volume":"69","author":"C Senore","year":"2020","unstructured":"Senore C, Zappa M, Campari C, Crotta S, Armaroli P, Arrigoni A, et al. Faecal haemoglobin concentration among subjects with negative FIT results is associated with the detection rate of neoplasia at subsequent rounds: a prospective study in the context of population based screening programmes in Italy. Gut. 2020;69:523\u201330. https:\/\/doi.org\/10.1136\/gutjnl-2018-318198.","journal-title":"Gut"},{"key":"5138_CR32","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1053\/j.gastro.2017.07.034","volume":"153","author":"EJ Grobbee","year":"2017","unstructured":"Grobbee EJ, Schreuders EH, Hansen BE, Bruno MJ, Lansdorp-Vogelaar I, Spaander MCW, et al. Association Between Concentrations of Hemoglobin Determined by Fecal Immunochemical Tests and Long-term Development of Advanced Colorectal Neoplasia. Gastroenterology. 2017;153:1251\u2013e12592. https:\/\/doi.org\/10.1053\/j.gastro.2017.07.034.","journal-title":"Gastroenterology"},{"key":"5138_CR33","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ejca.2018.11.004","volume":"107","author":"A Buron","year":"2019","unstructured":"Buron A, Rom\u00e1n M, Aug\u00e9 JM, Maci\u00e0 F, Grau J, Sala M, et al. Changes in FIT values below the threshold of positivity and short-term risk of advanced colorectal neoplasia: Results from a population-based cancer screening program. Eur J Cancer. 2019;107:53\u20139. https:\/\/doi.org\/10.1016\/j.ejca.2018.11.004.","journal-title":"Eur J Cancer"},{"key":"5138_CR34","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12876-023-02670-1","volume":"23","author":"ECH Breekveldt","year":"2023","unstructured":"Breekveldt ECH, Toes-Zoutendijk E, de Jonge L, Spaander MCW, Dekker E, van Kemenade FJ, et al. Personalized colorectal cancer screening: study protocol of a mixed-methods study on the effectiveness of tailored intervals based on prior f-Hb concentration in a fit-based colorectal cancer screening program (PERFECT-FIT). BMC Gastroenterol. 2023;23:45. https:\/\/doi.org\/10.1186\/s12876-023-02670-1.","journal-title":"BMC Gastroenterol"},{"key":"5138_CR35","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1056\/NEJMoa1301969","volume":"369","author":"R Nishihara","year":"2013","unstructured":"Nishihara R, Wu K, Lochhead P, Morikawa T, Liao X, Qian ZR, et al. Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy. N Engl J Med. 2013;369:1095\u2013105. https:\/\/doi.org\/10.1056\/NEJMoa1301969.","journal-title":"N Engl J Med"},{"key":"5138_CR36","doi-asserted-by":"publisher","first-page":"l6109","DOI":"10.1136\/bmj.l6109","volume":"367","author":"T Heisser","year":"2019","unstructured":"Heisser T, Peng L, Weigl K, Hoffmeister M, Brenner H. Outcomes at follow-up of negative colonoscopy in average risk population: systematic review and meta-analysis. BMJ. 2019;367:l6109. https:\/\/doi.org\/10.1136\/bmj.l6109.","journal-title":"BMJ"},{"key":"5138_CR37","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1001\/jamainternmed.2022.6215","volume":"183","author":"T Heisser","year":"2023","unstructured":"Heisser T, Kretschmann J, Hagen B, Niedermaier T, Hoffmeister M, Brenner H. Prevalence of Colorectal Neoplasia 10 or More Years After a Negative Screening Colonoscopy in 120 000 Repeated Screening Colonoscopies. JAMA Intern Med. 2023;183:183\u201390. https:\/\/doi.org\/10.1001\/jamainternmed.2022.6215.","journal-title":"JAMA Intern Med"},{"key":"5138_CR38","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1053\/j.gastro.2020.03.016","volume":"159","author":"PR Carr","year":"2020","unstructured":"Carr PR, Weigl K, Edelmann D, Jansen L, Chang-Claude J, Brenner H, et al. Estimation of Absolute Risk of Colorectal Cancer Based on Healthy Lifestyle, Genetic Risk, and Colonoscopy Status in a Population-Based Study. Gastroenterology. 2020;159:129\u2013e1389. https:\/\/doi.org\/10.1053\/j.gastro.2020.03.016.","journal-title":"Gastroenterology"},{"key":"5138_CR39","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1136\/gutjnl-2022-327188","volume":"72","author":"RGS Meester","year":"2023","unstructured":"Meester RGS, van de Schootbrugge-Vandermeer HJ, Breekveldt ECH, de Jonge L, Toes-Zoutendijk E, Kooyker A, et al. Faecal occult blood loss accurately predicts future detection of colorectal cancer. A prognostic model. Gut. 2023;72:101\u20138. https:\/\/doi.org\/10.1136\/gutjnl-2022-327188.","journal-title":"Gut"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-026-05138-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-05138-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-05138-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:49:45Z","timestamp":1787100585000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12916-026-05138-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5138"],"URL":"https:\/\/doi.org\/10.1186\/s12916-026-05138-7","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]},"assertion":[{"value":"5 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted following the Declaration of Helsinki and Good Clinical Practice guidelines. The study was approved by the ethics committees of Heidelberg University (178\/2005) and the state medical chambers of Baden\u2010W\u00fcrttemberg (M118\u201005\u2010f), Saarland (217\/13), Rhineland Palatinate (837.047.06(5145)) and Hesse (MC 254\/2007). All participants provided written informed consent to participate in the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"455"}}